Jonathan Meyer, MD
Interventional Cardiology · Munster, INNPI 1285021758
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.3%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Medtronic at 41.5% of the total. 2025 is the largest year on record at $7,238, more than ten times the $254 reported in 2020.
Across 259 payments — averaging $83.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Boston Scientific$4K
- Philips North America LLC$2K
- Edwards Lifesciences$666
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$632
- Abiomed$625
- plus $5K from 30 others
Across 1 payment — averaging $11,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Penumbra, Inc.$12K
What the payments were for
- Grants$4,00018%
- Travel & lodging$5,43525%
- Food & beverage$11,53953%
- Education$6803%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 55 | $8,988 |
| Boston Scientific | 47 | $4,248 |
| Philips North America LLC | 12 | $1,934 |
| Edwards Lifesciences | 7 | $666 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 38 | $632 |
| Abiomed | 7 | $625 |
| Acist Medical Systems, Inc. | 8 | $608 |
| Abbott | 8 | $449 |
| Biotronik Inc. | 4 | $398 |
| Teleflex LLC | 4 | $393 |
| Novartis | 16 | $366 |
| Shockwave Medical, Inc | 2 | $249 |
| United Therapeutics Corporation | 2 | $222 |
| Penumbra, Inc. | 3 | $200 |
| Angiodynamics, Inc. | 2 | $164 |
| Chiesi USA, Inc. | 5 | $148 |
| Inspire Medical Systems, Inc. | 3 | $138 |
| Cardiovascular Systems Inc. | 2 | $129 |
| W. L. Gore & Associates, Inc. | 2 | $116 |
| Endotronix, Inc. | 1 | $107 |
| GE HealthCare | 1 | $100 |
| Amgen | 6 | $98 |
| Sanofi-aventis U.S. LLC | 1 | $89 |
| Cathworks, Inc. | 1 | $84 |
| Inari Medical, Inc. | 3 | $83 |
| Pfizer | 4 | $82 |
| Johnson & Johnson | 3 | $68 |
| Scpharmaceuticals Inc. | 2 | $53 |
| AstraZeneca | 3 | $43 |
| AbbVie | 1 | $35 |
| Recor Medical Inc | 1 | $31 |
| Surmodics, Inc. | 1 | $30 |
| Merck | 1 | $22 |
| Atricure, Inc. | 1 | $19 |
| Terumo Medical Corporation | 1 | $18 |
| Cordis US CORP. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESOLUTE ONYX$4,149
- COREVALVE EVOLUT R$1,770
- TurboHawk$1,373
- GENERAL VASCULAR ACCESS$1,251
- (BQ9) Coronary IVUS$1,011
- SAPIEN 3 Ultra RESILIA$544
- Impella$429
- (6574) Coronary Other$422
- CVI SYSTEMS$404
- Resolute$280
- CARDIOMEMS$280
- AVVIGO Guidance System$264
- ReCross$233
- TrapIT$233
- PK Papyrus$233
- Orsiro Mission$233
- Pantera LEO$233
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$232
- GENERAL - THERAPIES$175
- TURNPIKE$163
How this compares
$21,654 in reported general payments places this provider in the 80th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 99 | $101,326 |
| EntrestoSacubitril/Valsartan | 49 | $48,649 |
| JardianceEmpagliflozin | 22 | $27,394 |
| XareltoRivaroxaban | 18 | $18,102 |
| FarxigaDapagliflozin Propanediol | 15 | $15,377 |
| Ranolazine ErRanolazine | 27 | $1,932 |
| ClopidogrelClopidogrel Bisulfate | 193 | $1,616 |
| Rosuvastatin Calcium | 133 | $1,202 |
| Metoprolol Succinate | 115 | $1,129 |
| Atorvastatin Calcium | 121 | $1,005 |
| Amlodipine Besylate | 54 | $486 |
| Bumetanide | 20 | $402 |
| Hydralazine Hcl | 35 | $371 |
| Furosemide | 118 | $331 |
| Carvedilol | 49 | $299 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $82 | $101,32699 claims |
| NovartisEntresto | $366 | $48,64949 claims |
| Johnson & JohnsonXarelto | $68 | $18,10218 claims |
| AstraZenecaFarxiga | $43 | $15,37715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 170 interventional cardiology providers in Indiana.
Other interventional cardiology in Munster
- Shashidhar DivakaruniMunster$97K
- Shadi HalabiMunster$31K
- Vinod NamanaMunster$20K
- Tariq HameedMunster$12K
- Asad TorabiMunster$11K
- Samer AbbasEast Chicago$395K
- James HermillerIndianapolis$307K
- Woodrow CoreyIndianapolis$262K
- Muzammil MusaniFort Wayne$184K
- Dean FerreraEast Chicago$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.